Quantification of Leishmania infantum Kinetoplast DNA for Monitoring the Response to Meglumine Antimoniate Therapy in Visceral Leishmaniasis
- 1 May 2013
- journal article
- research article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 88 (5) , 868-871
Abstract
Meglumine antimoniate (Glucantime) remains the therapeutic cornerstone of visceral leishmaniasis (VL). Twenty-one VL patients were treated with Glucantime, extending for 1 week after defervescence. For monitoring the response, Leishmania infantum kinetoplast DNA loads were evaluated using real-time polymerase chain reaction (PCR) assay in the blood. The maximum duration of treatment was 14 days. The loads before treatment ranged from 8 to 1,300,000 parasites/mL (mean = 73,095 parasites/mL), and the mean values on days 3, 7, 14, 28, and 90 were 4,902, 506, 6.33, 0.26, and 0.14, respectively. The loads decline to < 1 parasite/mL for 16 (76%) and 20 (95%) patients on days 14 and 28, respectively, and they decline for all patients by day 90. Results showed a dramatic decrease of the parasite loads, although complete clearance was not accomplished at the end of treatment. Only one relapse (4.5%) was observed. The parasite load can also serve as a dependable index for monitoring the response to Glucantime.Keywords
This publication has 25 references indexed in Scilit:
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future DirectionsMolecular Biology International, 2011
- Study of parasite kinetics with antileishmanial drugs using real-time quantitative PCR in Indian visceral leishmaniasisJournal of Antimicrobial Chemotherapy, 2011
- A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B TherapyPLOS Neglected Tropical Diseases, 2010
- Contribution of Quantitative Real-Time Polymerase Chain Reaction to Follow-Up of Visceral Leishmaniasis Patients Treated with Meglumine AntimoniateThe American Journal of Tropical Medicine and Hygiene, 2009
- Drug regimens for visceral leishmaniasis in Mediterranean countriesTropical Medicine & International Health, 2008
- Comparison between Quantitative Nucleic Acid Sequence-Based Amplification, Real-Time Reverse Transcriptase PCR, and Real-Time PCR for Quantification ofLeishmaniaParasitesJournal of Clinical Microbiology, 2008
- Advances in leishmaniasisThe Lancet, 2005
- Quantification of Leishmania infantum DNA by a Real-Time PCR Assay with High SensitivityJournal of Clinical Microbiology, 2004
- Potential role for interleukin-10 in the immunosuppression associated with kala azar.Journal of Clinical Investigation, 1993